Cytokinetics EVP Andrew Callos sells $144,565 in stock#Cytokinetics #EVP #Andrew #Callos #sells #stock
Tag: Cytokinetics
Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China By Investing.com
SOUTH SAN FRANCISCO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) — Cytokinetics (NASDAQ:), Incorporated (Nasdaq: CYTK) today…